Blockchain stocks appear to be the next big thing (or bubble) to trade with pure play blockchain stock Riot Blockchain Inc (NASDAQ: RIOT) closing up 47.59% on Friday and rising by a double digit percentage in premarket trading this morning while small cap Marathon Patent Group Inc (NASDAQ: MARA) surged 171.69% and is rising as much as 90% in premarket trading. Blockchains are decentralized digital ledgers that record and enable secure peer-to-peer transactions without third party intermediaries. They also form the basis for Bitcoin.
For Riot Blockchain, there appears to be no big company specific news to explain why investors/traders are now salivating beyond a Tuesday announcement of the appointment of Frank M. Bishop to the Company Advisory Board. Mr. Bishop served as a member of the senior management team that built INVESCO into one of the largest publicly traded global investment management companies.
Top Stocks To Watch For 2018: LaSalle Hotel Properties(LHO)
Advisors’ Opinion:
- [By Max Byerly]
Get a free copy of the Zacks research report on LaSalle Hotel Properties (LHO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Boenning Scattergood reaffirmed their hold rating on shares of LaSalle Hotel Properties (NYSE:LHO) in a research report report published on Friday.
- [By Paul Ausick]
LaSalle Hotel Properties (NYSE: LHO) fell about 14% Wednesday to post a new 52-week low of $24.00 after closing at $28.25 on Tuesday. The 52-week high is $31.75. Volume of about 12.2 million was more than 10 times the daily average. The company’s results were hit hard by Hurricane Irma.
- [By Joseph Griffin]
LaSalle Hotel Properties (NYSE:LHO) issued an update on its second quarter earnings guidance on Thursday morning. The company provided EPS guidance of $0.74-0.77 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.70. LaSalle Hotel Properties also updated its FY18 guidance to $2.16-2.19 EPS.
Top Stocks To Watch For 2018: Starwood Hotels & Resorts Worldwide, Inc.(HOT)
Advisors’ Opinion:
- [By Stephan Byrd]
Hydro Protocol (CURRENCY:HOT) traded up 15.6% against the US dollar during the 24-hour period ending at 19:00 PM ET on May 5th. During the last week, Hydro Protocol has traded up 93.2% against the US dollar. One Hydro Protocol token can currently be purchased for approximately $0.10 or 0.00001044 BTC on major exchanges including BigONE, DDEX and OKEx. Hydro Protocol has a total market cap of $72.13 million and approximately $1.91 million worth of Hydro Protocol was traded on exchanges in the last day.
Top Stocks To Watch For 2018: NBT Bancorp Inc.(NBTB)
Advisors’ Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on NBT Bancorp (NBTB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.
Top Stocks To Watch For 2018: Celanese Corporation(CE)
Advisors’ Opinion:
- [By Shane Hupp]
Celanese (NYSE: CE) and Sealed Air (NYSE:SEE) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.
- [By ]
Eli Lilly announced in October it was conducting a strategic review for the unit. Elanco on Monday said it has appointed Christopher Jensen, who was most recently with Celanese Corp. (CE) , as chief financial officer.
- [By Ethan Ryder]
Celanese (NYSE:CE)‘s stock had its “outperform” rating reiterated by Cowen in a report issued on Friday. They presently have a $125.00 price objective on the basic materials company’s stock, up from their previous price objective of $120.00. Cowen’s price objective would suggest a potential upside of 15.06% from the company’s previous close.
Top Stocks To Watch For 2018: Collegium Pharmaceutical, Inc.(COLL)
Advisors’ Opinion:
- [By Todd Campbell]
Depomed is in the middle of a restructuring of its business that includes out-licensing its lead drug, Nucynta. In December, Collegium (NASDAQ:COLL) cut a licensing deal for Nucynta that guarantees Depomed $135 million in annual royalties, paid quarterly in arrears, for four years. If sales exceed$233 million per year, then Collegium Pharmaceutical will also pay Depomed a double-digit royalty on top of the minimum license fee. After four years, Depomed will receive double-digit royalties on all net Nucynta sales.
- [By Logan Wallace]
Collegium Pharmaceutical (NASDAQ:COLL) – Piper Jaffray lowered their FY2021 EPS estimates for shares of Collegium Pharmaceutical in a note issued to investors on Wednesday, May 9th. Piper Jaffray analyst D. Amsellem now forecasts that the specialty pharmaceutical company will post earnings per share of $2.06 for the year, down from their previous forecast of $2.32. Piper Jaffray has a “Buy” rating and a $33.00 price target on the stock.
Top Stocks To Watch For 2018: BioCryst Pharmaceuticals Inc.(BCRX)
Advisors’ Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
